Page 197 - Genentech News Today

/PRNewswire/ -- GATC Health Corp, a technology company revolutionizing drug discovery and disease prediction using artificial intelligence (AI), announced that...

SCOTTSDALE, Ariz. — Several new drugs and promising therapies, including chimeric antigen receptor T-cell therapy, have ushered in a “lupus renaissance,” said a speaker at the Basic and Clinical Immunology for the Busy Clinician symposium. According to Emily Littlejohn, DO, MPH, of the Cleveland Clinic, other potential therapies for systemic lupus erythematosus that have emerged

Ismael “Izzy” Amado does the in-person work and sales with help from a company in Canada.

Investegate announcements from BioNTech SE, BioNTech Announces Establishment of Interdisciplinary mRNA Excellence Center to Conduct Research Jointly with Scientists from Weizmann Institute of Science in Israel

By Blake Brittain (Reuters) - Roche's Genentech Inc sued Biogen MA Inc on Tuesday in San Francisco federal court, claiming Biogen owes additional pate...

JERUSALEM, Israel, March 1, 2023 - BioNTech SE(Nasdaq: BNTX, "BioNTech", "the Company") announced that the Company and the Weizmann Institute of Science ("Weizmann Institute") signed a Memorandum

Business Oregon leaders discuss how the state's post-pandemic economic rebound is fueled by manufacturing, services, and wholesale trade.

Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Booster in Children Under 5 Years NEW YORK and... | March 1, 2023

By Blake Brittain (Reuters) - Roche's Genentech Inc sued Biogen MA Inc on Tuesday in San Francisco federal court, claiming Biogen owes additional pate...

By Blake Brittain (Reuters) - Roche's Genentech Inc sued Biogen MA Inc on Tuesday in San Francisco federal court, claiming Biogen owes additional pate...